(Q46148283)

English

Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

author name string

George Kephart

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

Marc E Richard

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

Charmaine A Cooke

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

25

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

1248-1257

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

Overview of nebuliser treatment

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Delays in managing lung cancer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Bronchodilator delivery in acute airflow obstruction. A meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Is nebulized aerosol treatment necessary in the pediatric emergency department?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

1998 revision of the Canadian Asthma Consensus Guidelines. Asthma Consensus Conference Editorial Committee

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Coping with asthma: the National Institutes of Health Asthma Guidelines

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

A review and economic evaluation of bronchodilator delivery methods in hospitalized patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.9.1248

21 January 2018

Identifiers

10.1592/PHCO.2005.25.9.1248

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/16164398

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46148283&oldid=2094987565"